Showing results (651-660 of 780) with videos related to
Sort By:
Pageof 78
The Oncologist|November 21, 2020
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study DesignJeffrey S Ross, Ethan S Sokol, Holger Moch, et al.The Oncologist|August 27, 2024
Genomic landscape of malignant phyllodes tumors reveals multiple targetable opportunitiesLaura H Rosenberger, Richard F Riedel, Emilia J Diego, et al.Neuroscience|October 16, 2007
Reduction of hippocampal cell death and proteolytic responses in tissue plasminogen activator knockout mice after transient global cerebral ischemiaS-R Lee, J Lok, A Rosell, et al.Journal of the National Cancer Institute|May 18, 2022
The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic ProfilingKumiko Umemoto, Hiroyuki Yamamoto, Ritsuko Oikawa, et al.NPJ Precision Oncology|December 20, 2024
Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitorsA Giannoudis, E S Sokol, T Bhogal, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2001
BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemiaN Plesnila, S Zinkel, D A Le, et al.Brain : a Journal of Neurology|July 20, 2007
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathyHwa Kyoung Shin, Phillip B Jones, Monica Garcia-Alloza, et al.The Oncologist|July 12, 2019
Pan-Cancer Analysis of CDK12 Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator PhenotypeEthan S Sokol, Dean Pavlick, Garrett M Frampton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast CarcinomaHope S Rugo, Kira Raskina, Alexa B Schrock, et al.Journal of Clinical Psychopharmacology|February 1, 1986
Alprazolam treatment of postcoronary bypass anxiety and depressionA M Freeman, L Fleece, D G Folks, et al.Pageof 78